Pediatrix Medical PE Ratio 2010-2025 | MD
Current and historical p/e ratio for Pediatrix Medical (MD) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Pediatrix Medical PE ratio as of June 26, 2025 is 8.91.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Pediatrix Medical PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-26 | 13.63 | 0.00 | |
| 2025-03-31 | 14.49 | $-1.01 | 0.00 |
| 2024-12-31 | 13.12 | $-1.20 | 0.00 |
| 2024-09-30 | 11.59 | $-3.06 | 0.00 |
| 2024-06-30 | 7.55 | $-3.03 | 0.00 |
| 2024-03-31 | 10.03 | $-0.85 | 0.00 |
| 2023-12-31 | 9.30 | $-0.73 | 0.00 |
| 2023-09-30 | 12.71 | $1.13 | 11.25 |
| 2023-06-30 | 14.21 | $1.24 | 11.46 |
| 2023-03-31 | 14.91 | $1.22 | 12.22 |
| 2022-12-31 | 14.86 | $0.80 | 18.58 |
| 2022-09-30 | 16.51 | $0.99 | 16.68 |
| 2022-06-30 | 21.01 | $0.98 | 21.44 |
| 2022-03-31 | 23.48 | $1.07 | 21.94 |
| 2021-12-31 | 27.21 | $1.53 | 17.78 |
| 2021-09-30 | 28.43 | $0.22 | 129.23 |
| 2021-06-30 | 30.15 | $-0.63 | 0.00 |
| 2021-03-31 | 25.47 | $-9.07 | 0.00 |
| 2020-12-31 | 24.54 | $-9.51 | 0.00 |
| 2020-09-30 | 16.28 | $-8.64 | 0.00 |
| 2020-06-30 | 17.10 | $-23.39 | 0.00 |
| 2020-03-31 | 11.64 | $-15.46 | 0.00 |
| 2019-12-31 | 27.79 | $-18.04 | 0.00 |
| 2019-09-30 | 22.62 | $-17.47 | 0.00 |
| 2019-06-30 | 25.23 | $-1.51 | 0.00 |
| 2019-03-31 | 27.17 | $-0.56 | 0.00 |
| 2018-12-31 | 33.00 | $2.93 | 11.26 |
| 2018-09-30 | 46.66 | $3.71 | 12.58 |
| 2018-06-30 | 43.28 | $3.70 | 11.70 |
| 2018-03-31 | 55.63 | $3.54 | 15.71 |
| 2017-12-31 | 53.44 | $3.45 | 15.49 |
| 2017-09-30 | 43.12 | $2.83 | 15.24 |
| 2017-06-30 | 60.37 | $3.16 | 19.10 |
| 2017-03-31 | 69.38 | $3.36 | 20.65 |
| 2016-12-31 | 66.66 | $3.50 | 19.05 |
| 2016-09-30 | 66.25 | $3.65 | 18.15 |
| 2016-06-30 | 72.43 | $3.58 | 20.23 |
| 2016-03-31 | 64.62 | $3.59 | 18.00 |
| 2015-12-31 | 71.66 | $3.58 | 20.02 |
| 2015-09-30 | 76.79 | $3.48 | 22.07 |
| 2015-06-30 | 74.11 | $3.37 | 21.99 |
| 2015-03-31 | 72.51 | $3.26 | 22.24 |
| 2014-12-31 | 66.11 | $3.17 | 20.85 |
| 2014-09-30 | 54.82 | $3.06 | 17.92 |
| 2014-06-30 | 58.15 | $2.96 | 19.65 |
| 2014-03-31 | 61.98 | $2.86 | 21.71 |
| 2013-12-31 | 53.38 | $2.78 | 19.24 |
| 2013-09-30 | 100.40 | $2.66 | 37.82 |
| 2013-06-30 | 91.58 | $2.56 | 35.84 |
| 2013-03-31 | 89.63 | $2.48 | 36.14 |
| 2012-12-31 | 79.52 | $2.42 | 32.86 |
| 2012-09-30 | 74.45 | $2.36 | 31.61 |
| 2012-06-30 | 68.54 | $2.29 | 29.93 |
| 2012-03-31 | 74.37 | $2.26 | 32.98 |
| 2011-12-31 | 72.01 | $2.24 | 32.22 |
| 2011-09-30 | 62.64 | $2.20 | 28.47 |
| 2011-06-30 | 72.19 | $2.25 | 32.08 |
| 2011-03-31 | 66.61 | $2.20 | 30.35 |
| 2010-12-31 | 67.29 | $2.13 | 31.59 |
| 2010-09-30 | 53.30 | $2.11 | 25.32 |
| 2010-06-30 | 55.61 | $1.98 | 28.16 |
| 2010-03-31 | 58.19 | $1.92 | 30.31 |
| 2009-12-31 | 60.11 | $1.89 | 31.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.171B | $2.013B |
| Pediatrix Medical Group Inc. is a national medical group comprised of physician services practicing under the Pediatrix(R) brand. It provides services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Pediatrix Medical Group Inc., formerly known as Mednax Inc., is based in FORT LAUDERDALE, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.850B | 26.98 |
| Elevance Health (ELV) | United States | $84.468B | 10.90 |
| CVS Health (CVS) | United States | $83.959B | 10.44 |
| Cencora (COR) | United States | $56.658B | 19.71 |
| DiDi Global (DIDIY) | China | $22.826B | 24.25 |
| Natera (NTRA) | United States | $22.415B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.653B | 17.56 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.432B | 0.00 |
| Solventum (SOLV) | United States | $12.967B | 13.73 |
| CochLear (CHEOY) | Australia | $12.826B | 0.00 |
| ICON (ICLR) | Ireland | $11.783B | 10.95 |
| Revvity (RVTY) | United States | $11.516B | 19.82 |
| Viatris (VTRS) | United States | $10.434B | 3.58 |
| Avantor (AVTR) | United States | $9.254B | 13.45 |
| HealthEquity (HQY) | United States | $8.991B | 39.38 |
| Medpace Holdings (MEDP) | United States | $8.943B | 23.75 |
| Sonic Healthcare (SKHHY) | Australia | $8.181B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.378B | 14.46 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.305B | 25.35 |
| BrightSpring Health Services (BTSG) | United States | $3.975B | 36.47 |
| Sotera Health (SHC) | United States | $3.162B | 17.97 |
| Surgery Partners (SGRY) | United States | $2.782B | 36.18 |
| Alignment Healthcare (ALHC) | United States | $2.710B | 0.00 |
| Concentras Parent (CON) | United States | $2.631B | 15.21 |
| Organon (OGN) | United States | $2.600B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.537B | 97.72 |
| PACS (PACS) | United States | $1.951B | 0.00 |
| Ardent Health (ARDT) | United States | $1.877B | 8.00 |
| Premier (PINC) | United States | $1.799B | 13.66 |
| Progyny (PGNY) | United States | $1.792B | 39.45 |
| GoodRx Holdings (GDRX) | United States | $1.754B | 35.07 |
| Teladoc Health (TDOC) | United States | $1.328B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.084B | 0.00 | |
| CareDx (CDNA) | United States | $1.064B | 16.62 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.670B | 10.14 |
| LifeMD (LFMD) | United States | $0.584B | 0.00 |
| Embecta (EMBC) | United States | $0.580B | 3.91 |
| InnovAge Holding (INNV) | United States | $0.516B | 0.00 |
| Enhabit (EHAB) | United States | $0.476B | 39.17 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| Sonida Senior Living (SNDA) | United States | $0.455B | 0.00 |
| Omada Health (OMDA) | $0.452B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.442B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.301B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.258B | 0.00 |
| Beauty Health (SKIN) | United States | $0.242B | 0.00 |
| Oncology Institute (TOI) | United States | $0.192B | 0.00 |
| So-Young (SY) | China | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.113B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.095B | 0.00 |
| KindlyMD (NAKA) | United States | $0.085B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |